Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Genpact Limited (NYSE:G) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 12,700 shares of the business services provider’s stock, valued at approximately $365,000.

Several other hedge funds also recently added to or reduced their stakes in G. YorkBridge Wealth Partners LLC lifted its holdings in Genpact by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock worth $106,000 after buying an additional 189 shares in the last quarter. Acrospire Investment Management LLC raised its stake in Genpact by 569.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 4,019 shares of the business services provider’s stock worth $112,000 after buying an additional 3,419 shares during the period. Meeder Asset Management Inc. acquired a new stake in Genpact during the 3rd quarter worth $128,000. Bronfman E.L. Rothschild L.P. raised its stake in Genpact by 1.9% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock worth $141,000 after buying an additional 94 shares during the period. Finally, Advisor Group Inc. raised its stake in Genpact by 59.8% during the 3rd quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock worth $145,000 after buying an additional 1,878 shares during the period. Institutional investors own 91.16% of the company’s stock.

Shares of Genpact Limited (NYSE:G) traded down $0.09 during trading hours on Wednesday, reaching $32.16. 1,607,600 shares of the company traded hands, compared to its average volume of 1,039,239. Genpact Limited has a twelve month low of $23.34 and a twelve month high of $32.51. The firm has a market cap of $6,225.62, a P/E ratio of 20.94, a P/E/G ratio of 2.20 and a beta of 0.58. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.65 and a quick ratio of 1.65.

Genpact (NYSE:G) last issued its earnings results on Tuesday, November 7th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.10. Genpact had a net margin of 10.18% and a return on equity of 23.86%. The business had revenue of $708.82 million during the quarter, compared to the consensus estimate of $685.25 million. During the same period last year, the business posted $0.37 EPS. Genpact’s revenue was up 9.3% on a year-over-year basis. equities research analysts anticipate that Genpact Limited will post 1.47 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 20th. Investors of record on Friday, December 8th will be paid a $0.06 dividend. The ex-dividend date is Thursday, December 7th. This represents a $0.24 annualized dividend and a yield of 0.75%. Genpact’s dividend payout ratio (DPR) is currently 17.39%.

In other Genpact news, insider Piyush Mehta sold 20,728 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The shares were sold at an average price of $30.00, for a total transaction of $621,840.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Private Ltd Gic sold 1,499,806 shares of the firm’s stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $30.26, for a total transaction of $45,384,129.56. The disclosure for this sale can be found here. Insiders sold a total of 1,575,051 shares of company stock valued at $47,739,747 over the last quarter. 1.41% of the stock is currently owned by company insiders.

A number of equities analysts have issued reports on the company. Robert W. Baird reiterated a “buy” rating and set a $38.00 target price on shares of Genpact in a report on Friday, November 10th. Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $35.00 target price for the company in a report on Friday, November 10th. Cantor Fitzgerald reiterated a “buy” rating and set a $36.00 target price on shares of Genpact in a report on Wednesday, November 8th. Wedbush reiterated an “outperform” rating and set a $33.00 target price on shares of Genpact in a report on Wednesday, August 9th. Finally, Cowen reiterated a “buy” rating and set a $33.00 target price on shares of Genpact in a report on Thursday, October 12th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Genpact presently has an average rating of “Buy” and a consensus price target of $33.38.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this piece of content can be accessed at https://theolympiareport.com/2017/12/06/zurcher-kantonalbank-zurich-cantonalbank-takes-position-in-genpact-limited-g.html.

Genpact Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.